temafloxacin syndrome

temafloxacin syndrome

Therapeutics A condition caused by temafloxacin characterized by vasculitis with microangiopathic hemolytic anemia, DIC, thrombocytopenia, renal dysfunction, hepatotoxicity, and CNS changes, including strokes Frequency 1/2000 Pts treated; it was withdrawn from the market. See Fluoroquinolone, Temafloxacin.
Mentioned in ?